As the sponsor of the Athlete Moment ... which has disrupted... NEW YORK/LONDON: Pfizer has clinched a US$10 billion deal to acquire obesity drug developer Metsera, ending a heated bidding war with ...
Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...
Quick Read Stocks had one of the worst weeks since April, and some feel that the selling could have more legs as we are only ...